PeptiDream Inc. | Income Statement

Fiscal year is July-June. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
819
2,474
4,328
4,896
6,427
Cost of Goods Sold (COGS) incl. D&A
315
722
1,087
1,366
1,779
Gross Income
504
1,752
3,241
3,530
4,648
SG&A Expense
288
361
693
1,040
1,737
EBIT
201
1,391
2,548
2,490
2,911
Unusual Expense
-
-
-
-
681
Non Operating Income/Expense
14
96
184
132
920
Pretax Income
222
1,493
2,366
2,624
3,152
Income Tax
73
489
785
733
817
Consolidated Net Income
149
1,004
1,581
1,891
2,335
Net Income
149
1,004
1,581
1,891
2,335
Net Income After Extraordinaries
149
1,004
1,581
1,891
2,335
Net Income Available to Common
149
1,004
1,581
1,891
2,335
EPS (Basic)
1.39
9.18
14.23
16.54
19.35
Basic Shares Outstanding
107
109
111
114
121
EPS (Diluted)
1.37
7.83
12.26
14.56
17.79
Diluted Shares Outstanding
109
128
129
130
131
EBITDA
275
1,494
2,691
2,685
3,424
Other Operating Expense
14
-
-
-
-
Non-Operating Interest Income
6
6
2
1
2

About PeptiDream

View Profile
Address
3-25-23 Tonomachi
Kawasaki Kanagawa 210
Japan
Employees -
Website http://www.peptidream.com
Updated 07/08/2019
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.